(Q77783220)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

review article

1 reference

title

The use of tricyclic antidepressants in children and adolescents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

J M Daly

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T Wilens

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

Pediatric Clinics of North America

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

1123-1135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

Current knowledge of medications for the treatment of childhood anxiety disorders.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Antidepressant treatments in children and adolescents. I. Affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

DSM-III disorders in preadolescent children. Prevalence in a large sample from the general population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

School phobia: a therapeutic trial with clomipramine and short-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Anxiety disorders of childhood and adolescence: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Comparative studies of pharmacotherapy for school refusal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Sudden death in children treated with a tricyclic antidepressant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

A double-blind placebo controlled study of desipramine in the treatment of ADD: I. Efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Panic disorder and agoraphobia in consecutively referred children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Panic disorder in children and adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Juvenile mood disorders and office psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder--a multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Obsessive compulsive disorder in adolescence: an epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Epidemiology of childhood depressive disorders: a critical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Tricyclic antidepressant and methylphenidate treatment of attention deficit disorder in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Panic disorder on a child psychiatric consultation service

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Commentary on unexplained death of children on Norpramin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine in the Treatment of Minimal Brain Dysfunction in Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Motor performance in hyperactive children treated with imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

A comparison of three nocturnal enuresis treatment methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Depression, depressive symptoms, and depressed mood among a community sample of adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine treatment of children with separation anxiety disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Clinical effects of amitriptyline in adolescent depression. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

The treatment of depressive states with G 22355 (imipramine hydrochloride).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Alterations in the vigilance performance of children receiving amitriptyline and methylphenidate pharmacotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Response to desipramine treatment in adolescent depression: a fixed-dose, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

A double-blind desipramine substitution during long-term clomipramine treatment in children and adolescents with obsessive-compulsive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Major depression in community adolescents: age at onset, episode duration, and time to recurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Abrupt cessation of high-dose imipramine treatment in children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Postmortem pharmacokinetics of tricyclic antidepressants: are some deaths during treatment misattributed to overdose?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Active metabolites of imipramine and desipramine in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine in prepubertal major depressive disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

One-year follow-up of hyperactive boys treated with imipramine or methylphenidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Methylphenidate and desipramine in hospitalized children: I. Separate and combined effects on cognitive function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Another sudden death in a child treated with desipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine in adolescent major depression: plasma level and clinical response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

The occurrence of behavior disorders in children: the interdependence of Attention Deficit Disorder and Conduct Disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Desipramine treatment of children with attention-deficit hyperactivity disorder and tic disorder or Tourette's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

The pharmacotherapy of depressive illness in adolescence: II. Effects of lithium augmentation in nonresponders to imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine and methylphenidate in hyperactive children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Imipramine in enuresis--psychological and physiological effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Nortriptyline in the treatment of ADHD: a chart review of 58 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Effects of Imipramine and Dextroamphetamine on Behavior of Neuropsychiatrically Impaired Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Amitriptyline and methylphenidate treatment of behaviorally disordered children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

Age at first onset for nonbipolar depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970065-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0031-3955(05)70065-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9884678%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference